Helicobacter pylori infection and ischemic heart disease: Could experimental data lead to clinical studies?(315 views) Ribaldone DG, Fagoonee S, Hickman I, Altruda F, Saracco GM, Pellicano R
Unit of Gastroenterology, Molinette Hospital, Via Cavour 31, Turin, 10126, Italy
Institute of Biostructure and Bioimaging (National Research Council), Molecular Biotechnology Center, University of Turin, Turin, Italy
Department of Nutrition and Dietetics, Princess Alexandra Hospital, Brisbane, Australia
Department of Oncology, University of Turin, Turin, Italy
References: Lemesle, G., Bauters, A., Bauters, C., Antithrombotic therapy in diabetic patients with coronary artery disease (2015) Panminerva Med, 57, pp. 87-9
Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., Heart disease and stroke ststistics-2014 update: A report from the American Heart Association (2014) Circulation, 128, pp. 1-268
Fahed, J., Floyd, K.C., Tighe, D.A., Sudden cardiac death in postmyocardial-infarction patients (2015) Panminerva Med, 57, pp. 71-86
Murray, C.J.L., Lopez, A.D., Global mortality, disability, and the contribution of risk factors: Global burden of disease study (1997) Lancet, 349, pp. 1436-1442
Helfand, M., Buckley, D.I., Freeman, M., Fu, R., Rogers, K., Fleming, C., Emerging risk factors for coronary heart disease: A summary of systematic reviews conducted for the U.S. Preventive Services Task Force (2009) Ann Intern Med, 151, pp. 496-507
Bainton, D., Jones, G.R., Hole, D., Influenza and ischaemic heart disease - A possible trigger for acute myocardial infarction? (1978) Int J Epidemiol, 7, pp. 231-239
Mattila, K.J., Nieminen, M.S., Valtonen, V.V., Rasi, V.P., Kesäniemi, Y.A., Syrjälä, S.L., Association between dental health and acute myocardial infarction (1989) BMJ, 298, pp. 779-781
Guiglia, R., Lo Russo, L., Coccia, E., Di Liberto, C., D'Angelo, M., Indovina, G., The association between periodontal diseases and cardiovascular diseases: A narrative review (2008) Panminerva Med, 50, pp. 327-337
Berrutti, M., Pellicano, R., Fagoonee, S., Astegiano, M., Smedile, A., Saracco, G., Potential relationship between Helicobacter pylori and ischemic heart disease: Any pathogenic model? (2008) Panminerva Med, 50, pp. 161-163
Kinjo, K., Sato, H., Sato, H., Shiotani, I., Kurotobi, T., Ohnishi, Y., Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction (2002) Circ J, 66, pp. 805-810
Folsom, A.R., Nieto, F.J., Sorlie, P., Chambless, L.E., Graham, D.Y., Helicobacter pylori seropositivity and coronary heart disease incidence atherosclerosis risk in communities (aric) study investigators (1998) Circulation, 98, pp. 845-850
McDonagh, T.A., Woodward, M., Morrison, C.E., McMurray, J.J., Tunstall-Pedoe, H., Lowe, G.D., Helicobacter pylori infection and coronary heart disease in the north glasgow monica population (1997) Eur Heart J, 18, pp. 1257-1260
Liu, J., Wang, F., Shi, S., Helicobacter pylori infection increase the risk of myocardial infarction: A meta-analysis of 26 studies involving more than 20,000 participants (2015) Helicobacter, 20, pp. 176-183
Oderda, G., Marietti, M., Pellicano, R., Diagnosis and treatment of Helicobacter pylori infection in pediatrics: Recommendation for 2014 clinical practice (2015) Minerva Pediatr, 67, pp. 517-524
Rosso, C., Fagoonee, S., Altruda, F., Pellicano, R., Update on colonization, survival and antibiotic resistance of Helicobacter pylori at the molecular level (2015) Minerva Biotec, 27, pp. 149-157
Fagoonee, S., Li, H., Zhang, H., Altruda, F., Pellicano, R., Gastric cancer as a stem-cell disease: Data and hypotheses (2014) Panminerva Med, 56, pp. 289-300
Adriani, A., Repici, A., Hickman, I., Pellicano, R., Helicobacter pylori infection and respiratory diseases: Actual data and directions for future studies (2014) Minerva Med, 105, pp. 1-8
Ribaldone, D.G., Fagoonee, S., Colombini, J., Saracco, G., Astegiano, M., Pellicano, R., Helicobacter pylori infection and asthma: Is there a direct or an inverse association? Ameta-analysis (2016) World J Meta-Anal, 4, pp. 63-68
Adriani, A., Fagoonee, S., De Angelis, C., Altruda, F., Pellicano, R., Helicobacter pylori infection and dementia: Can actual data reinforce the hypothesis of a causal association? (2014) Panminerva Med, 56, pp. 195-199
Malfertheiner, P., Mégraud, F., O'Morain, C., Atherton, J., Axon, A.T.R., Bazzoli, F., Management of helicobacter pylori infection: The Maastricht IV/florence consensus report (2012) Gut, 61, pp. 646-664
Crossman, D., The future of the management of ischaemic heart disease (1997) BMJ, 314, pp. 356-359
Tong, D.C., Wilson, A.M., Layland, J., Novel risk factors for acute coronary syndromes and emerging therapies (2016) Int J Cardiol, 220, pp. 815-824
Ridker, P.M., Hennekens, C.H., Buring, J.E., Rifai, N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women (2000) NEJM, 342, pp. 836-843
De Boer, O.J., Van Der Wal, A.C., Becker, A.E., Atherosclerosis, inflammation, and infection (2000) J Pathol, 190, pp. 237-243
Sjöbring, U., Ringdahl, U., Ruggeri, Z.M., Induction of platelet thrombi by bacteria and antibodies (2002) Blood, 100, pp. 4470-4477
Piro, M., Giubilato, G., Pinnelli, M., Giordano Sciacca, P., Biasucci, L.M., Endothelium and inflammation (2005) Panminerva Med, 47, pp. 75-80
Byrne, M.F., Kerrigan, S.W., Corcoran, P.A., Atherton, J.C., Murray, F.E., Fitzgerald, D.J., Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation (2003) Gastroenterology, 124, pp. 1846-1854
Grabczewska, Z., Nartowicz, E., Kubica, J., Rosc, D., Endothelial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumoniae (2006) Eur J Intern Med, 17, pp. 339-342
Frishman, W.H., Biologic markers as predictors of cardiovascular disease (1998) Am J Med, 104 (6 A), pp. 18S-27S
Elizalde, J.I., Pérez-Pujol, S., Heras, M., Sionis, A., Casanovas, N., Martorell, T., Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes (2004) Helicobacter, 9, pp. 681-689
Elizalde, J.I., Gómez, J., Panés, J., Lozano, M., Casadevall, M., Ramírez, J., Platelet activation in mice and human Helicobacter pylori infection (1997) J Clin Invest, 100, pp. 996-1005
Jang, Y., Lincoff, A.M., Plow, E.F., Topol, E.J., Cell adhesion molecules in coronary artery disease (1994) J. Am Coll Cardiol, 24, pp. 1591-1601
Kalia, N., Bardhan, K.D., Reed, M.W., Jacob, S., Brown, N.J., Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo (2000) Dig Dis Sci, 45, pp. 1343-1351
Aguejouf, O., Mayo, K., Monteiro, L., Doutremepuich, F., Doutremepuich, C., Megraud, F., Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice (2002) Thromb Res, 108, pp. 245-248
Consolazio, A., Borgia, M.C., Ferro, D., Iacopini, F., Paoluzi, O.A., Crispino, P., Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic Helicobacter pylori-positive gastritis (2004) Aliment Pharmacol Ther, 20, pp. 289-294
Gensini, G.F., Conti, A.A., The preventive and therapeutic impact of antiplatelet agents: Past and present (2009) Minerva Med, 100, pp. 133-136
Patel, P., Mendall, M.A., Carrington, D., Strachan, D.P., Leatham, E., Molineaux, N., Association of Helicobacter pylori and (1995) Chlamydia Pneumoniae Infections with Coronary Heart Disease and Cardiovascular Risk Factors. BMJ, 311, pp. 711-714
Zito, F., Di Castelnuovo, A., D'Orazio, A., Negrini, R., De Lucia, D., Donati, M.B., Helicobacter pylori infection and the risk of myocardial infarction: Role of fibrinogen and its genetic control (1999) Thromb Haemost, 82, pp. 14-18
Parente, F., Imbesi, V., Cucino, C., Maconi, G., Russo, U., Duca, P.G., Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals (2000) J Intern Med, 247, pp. 213-217
Torgano, G., Cosentini, R., Mandelli, C., Perondi, R., Blasi, F., Bertinieri, G., Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease (1999) Circulation, 99, pp. 1555-1559
Pellicano, R., Oliaro, E., Fagoonee, S., Astegiano, M., Berrutti, M., Saracco, G., Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication (2009) Int Angiol, 28, pp. 469-473
Yusuf, S.W., Mishra, R.M., Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease (2002) Acta Cardiol, 57, pp. 317-322
Ando, T., Minami, M., Ishiguro, K., Maeda, O., Watanabe, O., Mizuno, T., Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication (2006) Aliment Pharmacol Ther, 24, pp. 58-64
Buzás, G.M., Metabolic consequences of Helicobacter pylori infection and eradication (2014) World J Gastroenterol, 20, pp. 5226-5234
Hatz, R.A., Rieder, G., Stolte, M., Bayerdörffer, E., Meimarakis, G., Schildberg, F.-W., Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis (1997) Gastroenterology, 112, pp. 1908-1919
Cover, T.L., Blaser, M.J., Helicobacter pylori in health and disease (2009) Gastroenterology, 136, pp. 1863-1873
Singh, R.K., McMahon, A.D., Patel, H., Packard, C.J., Rathbone, B.J., Samani, N.J., Prospective analysis of the association of infection with CagAbearing strains of Helicobacter pylori and coronary heart disease (2002) Heart, 88, pp. 43-46
Khodaii, Z., Vakili, H., Ghaderian, S.M., Najar, R.A., Panah, A.S., Association of Helicobacter pylori infection with acute myocardial infarction (2011) Coron Artery Dis, 22, pp. 6-11
Figura, N., Palazzuoli, A., Faglia, S., Lenzi, C., Borrello, F., Palazzuoli, V., Infection by caga-positive helicobacter pylori strains in patients with ischemic heart disease: Prevalence and association with exercise-induced electrocardiographic abnormalities (2002) Dig Dis Sci, 47, pp. 831-836
Pellicano, R., Parravicini, P.P., Bigi, R., Gandolfo, N., Aruta, E., Gai, V., Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference? (2002) New Microbiol, 25, pp. 315-321
Franceschi, F., Niccoli, G., Ferrante, G., Gasbarrini, A., Baldi, A., Candelli, M., CagAantigen of Helicobacter pylori and coronary instability: Insight from a clinico-pathological study and a meta-analysis of 4241 cases (2009) Atherosclerosis, 202, pp. 535-542
Franceschi, F., Sepulveda, A.R., Gasbarrini, A., Pola, P., Gentiloni Silveri, N., Gasbarrini, G., Cross-reactivity of anti-CagAantibodies with vascular wall antigens. Possible pathogenic link between Helicobacter pylori infection and atherosclerosis (2002) Circulation, 106, pp. 430-434
Schöttker, B., Adamu, M.A., Weck, M.N., Müller, H., Brenner, H., Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: A population-based cohort study (2012) Atherosclerosis, 220, pp. 569-574
Goll, R., Gruber, F., Olsen, T., Cui, G., Raschpichler, G., Buset, M., Helicobacter pylori stimulates a mixed adaptive immune response with a strong T-regulatory component in human gastric mucosa (2007) Helicobacter, 12, pp. 185-192
Gurfinkel, E.P., De La Fuente, R.L., Mendiz, O., Mautner, B., Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: The flu vaccination acute coronary syndromes (fluvacs) study (2002) Circulation, 105, pp. 2143-2147
Zhu, J., Katz, R.J., Quyyumi, A.A., Canos, D.A., Rott, D., Csako, G., Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: Suggestion of pathogen-triggered autoimmunity in early atherosclerosis (2004) Circulation, 109, pp. 36-41
Lenzi, C., Palazzuoli, A., Giordano, N., Alegente, G., Gonnelli, C., Campagna, M.S., H. Pylori infection and systemic antibodies to CagAand heat shock protein 60 in patients with coronary heart disease (2006) World J Gastroenterol, 12, pp. 7815-7820
Ayada, K., Yokota, K., Kobayashi, K., Shoenfeld, Y., Matsuura, E., Oguma, K., Chronic infections and atherosclerosis (2009) Clin Rev Allergy Immunol, 37, pp. 44-48
Birnie, D.H., Holme, E.R., McKay, I.C., Hood, S., McColl, K.E., Hillis, W.S., Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk (1998) Eur Heart J, 19, pp. 387-394
Tamer, G.S., Tengiz, I., Ercan, E., Duman, C., Alioglu, E., Turk, U.O., Helicobacter pylori seropositivity in patients with acute coronary syndromes (2009) Dig Dis Sci, 54, pp. 1253-1256
Leinonen, M., Linnanmäki, E., Mattila, K., Nieminen, M.S., ValtonenV Leirisalo-Repo, M., Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction (1990) Microb Pathog, 9, pp. 67-73
Szklo, M., Ding, J., Tsai, M.Y., Cushman, M., Polak, J.F., Lima, J., Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (2009) J Cardiovasc Med, 10, pp. 747-751
Kucukazman, M., Yavuz, B., Sacikara, M., Asilturk, Z., Ata, N., Ertugrul, D.T., The relationship between updated Sydney system score and ldlcholesterol levels in patients infected with Helicobacter pylori (2009) Dig Dis Sci, 54, pp. 604-607
Longo-Mbenza, B., Nkondi Nsenga, J., Vangu Ngoma, D., Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics (2007) Int J Cardiol, 121, pp. 229-238
Niemelä, S., Karttunen, T., Korhonen, T., Läärä, E., Karttunen, R., Ikäheimo, M., Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? (1996) Heart, 75, pp. 573-575
Huang, B., Chen, Y., Xie, Q., Lin, G., Wu, Y., Feng, Y., CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease (2011) Dig Dis Sci, 56, pp. 109-114
McGee, D.J., George, A.E., Trainor, E.A., Horton, K.E., Hildebrandt, E., Testerman, T.L., Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37 (2011) Antimicrob Agents Chemother, 55, pp. 2897-2904
Khan, S., Rahman, H.N.A., Okamoto, T., Matsunaga, T., Fujiwara, Y., Sawa, T., Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses (2014) Sci Rep, 4, p. 4680
Budoff, M.J., Achenbach, S., Blumenthal, R.S., Carr, J.J., Goldin, J.G., Greenland, P., Assessment of coronary artery disease by cardiac computed tomography: A scientific statement from the American Heart Association committee on cardiovascular imaging and intervention, council on cardiovascular radiology and intervention, and committee on cardiac imaging, council on clinical cardiology (2006) Circulation, 114, pp. 1761-1791
Park, M.J., Choi, S.H., Kim, D., Kang, S.J., Chung, S.J., Choi, S.Y., Association between Helicobacter pylori seropositivity and the coronary artery calcium score in a screening population (2011) Gut Liver, 5, pp. 321-327
Laek, B., Szklo, M., McClelland, R.L., Ding, J., Tsai, M.Y., Bluemke, D.A., The prospective association of Chlamydia pneumoniae and four other pathogens with development of coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis (MESA) (2013) Atherosclerosis, 230, pp. 268-274
Kowalski, M., Rees, W., Konturek, P.C., Grove, R., Scheffold, T., Meixner, H., Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina (2002) Dig Liver Dis, 34, pp. 398-402
Izadi, M., Fazel, M., Sharubandi, S.H., Saadat, S.H., Farahani, M.M., Nasseri, M.H., Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease (2012) Cardiovasc Pathol, 21, pp. 307-311
Iriz, E., Cirak, M.Y., Engin, E.D., Zor, M.H., Erer, D., Ozdogan, M.E., Detection of Helicobacter pylori DNAin aortic and left internal mammary artery biopsies (2008) Tex Heart Inst J, 35, pp. 130-135
Kilic, A., Onguru, O., Tugcu, H., Kilic, S., Guney, C., Bilge, Y., Detection of cytomegalovirus and Helicobacter pylori DNAin arterial walls with grade IIIatherosclerosis by PCR (2006) Pol J Microbiol, 55, pp. 333-337
Adiloglu, A.K., Ocal, A., Can, R., Duver, H., Yavuz, T., Aridogan, B.C., Detection of Helicobacter pylori and Chlamydia pneumoniae DNAin human coronary arteries and evaluation of the results with serologic evidence of inflammation (2005) Saudi Med J, 26, pp. 1068-1074
Jia, E.Z., Zhao, F.J., Hao, B., Zhu, T.B., Wang, L.S., Chen, B., Helicobacter pylori infection is associated with decreased serum levels of high-density lipoprotein, but not with the severity of coronary atherosclerosis (2009) Lipids Health Dis, 8, p. 59
Lutsey, P.L., Pankow, J.S., Bertoni, A.G., Szklo, M., Folsom, A.R., Serological evidence of infections and type 2 diabetes: The multiethnic study of atherosclerosis (2009) Diabet Med, 26, pp. 149-152
Moosazadeh, M., Shahbazi, N., Mahmoodi, G., Abdi Joubari, H., Mahdavi, S.A., Babania Rostam, F.Z., The relationship between the prevalence of Helicobacter pylori and serum levels of vitamin B12 in women 10-49 years (2015) Minerva Gastroenterol Dietol, 61, pp. 131-135
Redéen, S., Ryberg, A., Petersson, F., Eriksson, O., Nägga, K., Borch, K., Homocysteine levels in chronic gastritis and other conditions: Relations to incident cardiovascular disease and dementia (2010) Dig Dis Sci, 55, pp. 351-358
Antoniades, C., Antonopoulos, A.S., Tousoulis, D., Marinou, K., Stefanadis, C., Homocysteine and coronary atherosclerosis: From folate fortification to the recent clinical trials (2009) Eur Heart J, 30, pp. 6-15
Evrengul, H., Tanriverdi, H., Kuru, O., Enli, Y., Yuksel, D., Kilic, A., Elevated homocysteine levels in patients with slow coronary flow: Relationship with Helicobacter pylori infection (2007) Helicobacter, 12, pp. 298-305
Garfunkel, E., Bozovich, G., Daroca, A., Beck, E., Mautner, B., Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study (1997) Lancet, 350, pp. 404-407
Gupta, S., Leatham, E.W., Carrington, D., Mendall, M.A., Kaski, J.C., Camm, J., Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction (1997) Circulation, 96, pp. 404-407
Stone, A.F.M., Mendall, M.A., Kaski, J., Edger, T.M., Risley, P., Poloniecki, J., Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes. South Thames trial of antibiotics in myocardial infarction and unstable angina (STAMINA) (2002) Circulation, 106, pp. 1219-1223
Zahn, R., Schneider, S., Frilling, B., Seidl, K., Tebbe, U., Weber, M., Antibiotic therapy after acute myocardial infarction. Aprospective randomized study (2003) Circulation, 107, pp. 1253-1259
Pellicano, R., Lipid profile and Helicobacter pylori infection (2010) J Atheroscler Thromb, 17, pp. 1199-1200
Lam, V., Su, J., Hsu, A., Gross, G.J., Salzman, N.H., Baker, J.E., Intestinal microbial metabolites are linked to severity of myocardial infarction in rats (2016) PLOS One, 11, p. e0160840
Catanzaro, R., Anzalone, M., Calabrese, F., Milazzo, M., Capuana, M., Italia, A., The gut microbiota and its correlations with the central nervous system disorders (2015) Panminerva Med, 57, pp. 127-143
Catanzaro, R., Occhipinti, S., Calabrese, F., Anzalone, M.G., Milazzo, M., Italia, A., Irritable bowel syndrome: New findings in pathophysiological and therapeutic field (2014) Minerva Gastroenterol Dietol, 60, pp. 151-163
Helicobacter pylori infection and ischemic heart disease: Could experimental data lead to clinical studies?
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(341 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote